Uncertainty-aware biological age clocks and disease risk in UK Biobank
A proposed framework adds calibrated prediction intervals to biological age clocks; in UK Biobank, wider intervals were independently associated with disease risk and mortality for some clocks, and findings were replicated in Biobank Japan and a Stanford cohort. [1]
Automatic summary · not editorially reviewed
The key findings
The authors propose a framework that adds calibrated prediction intervals and individualized probabilities of accelerated or decelerated aging to biological age point estimates. [1]
In the UK Biobank Pharma Proteomics Project, three composite and eleven organ-specific clocks were evaluated, and predictive uncertainty varied within and across clocks. [1]
Prediction-interval width was independently associated with disease risk and mortality, particularly for composite, brain and immune clocks, and findings were replicated in Biobank Japan and a Stanford cohort. [1]
The source at a glance
- Study type / format
- Abstract of a methods-development and cohort association study
- Population / context
- Participants in the UK Biobank Pharma Proteomics Project, with replication in Biobank Japan and an independent Stanford clinical cohort.
- Summary based on
- Study abstract
- Publication status
- Preprint · peer-review status not confirmed
- Original publication
- August 5, 2026
Proposed framework for clock prediction uncertainty
The authors describe a framework for uncertainty-aware biological aging. Alongside point estimates, it produces calibrated prediction intervals and individualized probabilities of accelerated or decelerated aging. The stated motivation: biological age estimates are increasingly used to study aging, disease risk and mortality, yet their predictive uncertainty is rarely quantified. Conventional age-gap measures can therefore treat deviations as equally informative even when the underlying predictions differ substantially in reliability. This is a proposed framework, not a validated product.
Supporting source [1]
UK Biobank clocks: uncertainty and risk associations
The framework was applied to the UK Biobank Pharma Proteomics Project, evaluating three composite and eleven organ-specific biological age clocks. Predictive uncertainty varied substantially both within and across clocks. Apparently extreme age gaps could differ markedly in the strength of evidence for accelerated or decelerated aging. Low-accuracy clocks, including many organ-specific clocks, provided little evidence for confidently accelerated or decelerated aging. Beyond age gaps, prediction-interval width was independently associated with disease risk and mortality, particularly for composite, brain and immune clocks. The authors suggest this may reflect increased molecular heterogeneity and dysregulation associated with aging and disease. These are associations, not causal effects.
Supporting source [1]
Replication and abstract-only scope
The authors report replicating these findings in Biobank Japan and an independent clinical cohort from Stanford. They state that incorporating individual-specific predictive uncertainty provides a more informative characterization of biological aging and enables improved individual-level risk stratification for disease prevention and longitudinal monitoring. This is a stated aim, not a demonstrated clinical benefit. Only the abstract was reviewed; the full text was not reviewed. Design details, sample sizes, follow-up and effect sizes are not reported in the abstract, so the strength of the replication and the risk associations cannot be judged from it.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. Design details, sample sizes, follow-up and effect sizes are not reported in the abstract. The framework is proposed, not validated. Associations are not causal, and improved risk stratification is a stated aim, not a demonstrated clinical benefit.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Wang C, Wu H, Namba S, Park JY, the BioBank Japan Project, Matsuda K, Okada Y, He Z, Ionita-Laza I. · europepmc.org · August 5, 2026